Microtoxin (intradermal injection): what it is

Microtoxin is the name given to the injection of well-diluted botulinum toxin in many small droplets spread through the dermis or just below it. It also appears as microbotox, mesobotox, or intradermal toxin. The logic differs from the classic injection: instead of blocking the contraction of a whole muscle to soften a dynamic wrinkle, the aim is to act on skin structures and on the most superficial muscle fibers that insert into it.

The technique took off on social media as "botox for pores," "glass skin," or "lifting without filler," and that is where the problem lies: the promise travels faster than the evidence. This review guide lays out what is known, where the technique is usually used, what weighs against it, how the label question stands, and how to talk with the patient. Dilution, units, and injection point maps are left out on purpose: they depend on the product, on training, and on the decision of the qualified professional, following the rules of their professional board.

How does microtoxin act on the skin?

Botulinum toxin blocks the release of acetylcholine at the nerve terminal. In intramuscular injection, the target is the neuromuscular junction; the fundamentals are in botulinum toxin: fundamentals. In the skin, acetylcholine also takes part in controlling other structures, and that is what microtoxin bets on:

• Eccrine sweat glands: they have cholinergic innervation. This is the best-established mechanism, and hyperhidrosis is among the labeled indications of some products.
• Sebaceous glands: studies suggest that acetylcholine stimulates sebum production; reducing that stimulus could lower oiliness. The exact mechanism is still debated.
• Arrector pili muscle and dermal fibers: some authors link the effect on pores and texture to these structures, but it is a hypothesis, not a consensus.
• Superficial muscle fibers: a droplet close to the surface can weaken only the most superficial portion of muscles such as the platysma, which inserts into the skin, without paralyzing the whole muscle. This is the rationale behind proposals for the neck and jawline.

There is also work on flushing and facial redness, with hypotheses involving modulation of mediators in the skin. These are small studies, and the dermatological indication for conditions such as rosacea belongs to its own clinical assessment.

What is microtoxin usually proposed for?

Note the last column. In every row, microtoxin is a possibility of mild improvement, usually shorter-lasting than muscle injection, with a response that varies a lot between patients.

What sets microtoxin apart from traditional toxin?

One technical point that often goes unnoticed: toxin units are not interchangeable between products, and this holds even more when diluting. The same "recipe" seen in a course with one product does not carry over to another. The differences between brands and formulations are in differences between botulinum toxins type A.

Is microtoxin off-label use?

In most cosmetic proposals, yes. The labels of botulinum toxins registered with ANVISA (Brazil's health regulatory agency) describe specific indications, routes, areas, and preparation. Using the product at another dilution, by another route, or for another purpose is off-label use: it is not forbidden in itself, but it remains the responsibility of whoever prescribes it and requires a technical basis and clear information to the patient.

Two situations deserve extra attention:

• Mixing in the same syringe. Combining toxin with skinbooster or other actives to inject together is a widespread practice, but the stability and activity of the toxin in these mixtures are not described on the label. This widens the off-label nature and the uncertainty of the result.
• Splitting and storage. Diluting more and using the vial over several sessions runs into shelf life after reconstitution, asepsis, and the cold chain. The rules of the product and of health surveillance come before convenience; see botulinum toxin storage.

What are the risks and precautions?

The general risks of botulinum toxin apply, and the technique-specific ones come from the number of punctures and the superficial spread.

Local and passing: erythema, papules at the points in the first hours, small ecchymoses, tenderness to touch. In higher phototypes, repeated trauma calls for care regarding hyperpigmentation, as discussed in facial harmonization in Black skin.

From spread: grid injection, with a larger volume of liquid, can reach expression muscles that were not the target. In the lower third of the face, this can mean a weak smile, difficulty speaking or closing the lips, and an asymmetric smile. In the neck, there are reports of neck weakness and, at high doses, discomfort when swallowing. Near the eyes, eyelid changes. These conditions are covered in complications with botulinum toxin.

Systemic and immunological: the same as for toxin in general. Frequent repeated exposure to relevant total doses enters the discussion on neutralizing antibodies and loss of response, the topic of botulinum toxin treatment failure. Microtoxin is not a "negligible dose" when the area is large.

Who is not a good candidate?

The general contraindications of toxin apply here: neuromuscular junction disorders, pregnancy and breastfeeding, active infection in the area, use of drugs that interfere with neuromuscular transmission, and known hypersensitivity to the components, among others listed on the label. See general contraindications in facial harmonization.

Beyond those, some profiles call for caution or a different approach:

• A patient whose main concern is laxity or volume loss: microtoxin does not restore structure, and a neck with loose skin tends to respond poorly. Assessment in lower third laxity.
• Inflammatory acne, active rosacea, or dermatitis: the underlying diagnosis and treatment come first, with the appropriate professional.
• Expectation of "glass skin" or an effect like a photo filter.
• People who rely heavily on lower-face expression for work (singers, wind instrument players, actors, teachers) and do not accept the risk of weakness.

How does it compare with skinbooster and other skin options?

When the concern is texture, glow, or fine lines, microtoxin competes with options that work by another mechanism. Skinbooster hydrates and improves skin quality; polynucleotides and biostimulators act on regeneration and collagen; microneedling stimulates repair. The comparisons are in skinbooster or polynucleotides and in microneedling with a biostimulator or hyaluronic acid.

In practice, the useful question is which mechanism explains that patient's concern. Oiliness and enlarged pores in a young face are one conversation. Thin, dehydrated skin with lost elasticity is another. Horizontal neck lines with a marked platysmal band are yet another, covered in botulinum toxin for platysmal bands.

How to explain it to the patient

The patient arrives asking for the name they saw on social media. The honest conversation separates what the technique can do from what the video promised.

Take photos beforehand, with the same light and position you will use at the follow-up, because subtle texture changes are hard to judge from memory. The standard is in standardized clinical photography.

And in Harmy?

Checklist before recommending microtoxin

1. Concern defined: oiliness, pores, fine lines, contour, or sweating.
2. Underlying diagnosis assessed (acne, rosacea, dermatitis, laxity).
3. General toxin contraindications checked in the medical history.
4. Product label read and off-label nature explained.
5. Specific consent signed, with spread risks described.
6. Standardized photos beforehand, with the same light as the follow-up.
7. Product, lot, expiry, and preparation recorded.
8. Warning-sign instructions given in writing and follow-up scheduled.